
Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial
(Reuters) -Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as reducing waist circumference, citing data from a head-to-head trial....
- May 11, 2025 03:06 PM PDT
- EODHD

Inflation Reports, Walmart, Cisco Earnings; and More to Watch This Week
Simon Property, Sony, Alibaba, and Deere will also report earnings. Economic releases this week will include data on inflation, producer prices, and retail sales. Continue Reading View Comments
- May 11, 2025 11:00 AM PDT
- EODHD

OpenAI and Microsoft renegotiate multibillion-dollar partnership terms - report
Investing.com -- OpenAI and Microsoft Corporation (NASDAQ:MSFT) are currently in discussions to revise the terms of their multibillion-dollar partnership, according to a Financial Times report on Sund...
- May 11, 2025 10:12 AM PDT
- EODHD

Prediction: This Artificial Intelligence (AI) Semiconductor Stock Will Soar After May 28
Most of the major players in the AI landscape have already delivered their Q1 earnings reports -- but Nvidia's results are still to come.
- May 11, 2025 09:21 AM PDT
- EODHD